{
  "catalogId": "a76aacd1-3fe3-482b-82fb-86c058e4d69a",
  "name": "ELREXFIO",
  "status": "draft",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "177 77 37990 00",
  "treatmentDescriptions": "ELREXFIO is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 antibody and have demonstrated disease progression on the last therapy.",
  "termsOfIssue": "Prescription required",
  "form": "solution for injection",
  "route": "s.c",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "ELRANATAMAB/",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "L01FX32",
      "name": "ELRANATAMAB"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרתתרופה הנרכשת ע'י משרד הבריאות",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "ELREXFIO 44MG/1.1ML 1 VIAL",
      "manufacturer": {
        "name": "פיזר",
        "countryOfOrigin": "IL"
      },
      "strength": [],
      "quantity": {
        "value": 1.0,
        "unit": "units"
      },
      "packagingDescription": "VIAL GLASS TYPE I",
      "shelfLife": "24",
      "storageConditions": "",
      "codes": {
        "moh": "9551",
        "barcode": "5415062123577"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 13113.45791,
        "retailMargin": 10.0,
        "maxRetailPrice": 14424.8037,
        "maxPriceWithVAT": 17021.26761
      },
      "formulation": ""
    }
  ],
  "metadata": {
    "version": "1.5",
    "lastUpdated": "2025-08-01T18:03:53.329636"
  }
}